Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 35.19 10.80 3.62 16.23 11.26
Fund with Sales Charge (%) (POP) 35.19 10.80 3.62 16.23 11.26
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81
Quarter EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 35.19 10.80 3.62 16.23 11.26
Fund with Sales Charge (%) (POP) 35.19 10.80 3.62 16.23 11.26
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81

After-Tax Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 32.52 9.43 2.11 14.76
Fund without Sales Charge (%) (NAV) After Shares Sold 22.76 8.21 2.48 13.37
Fund with Sales Charge (%) (POP) Before Shares Sold 32.52 9.43 2.11 14.76
Fund with Sales Charge (%) (POP) After Shares Sold 22.76 8.21 2.48 13.37
Quarter EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 32.52 9.43 2.11 14.76
Fund without Sales Charge (%) (NAV) After Shares Sold 22.76 8.21 2.48 13.37
Fund with Sales Charge (%) (POP) Before Shares Sold 32.52 9.43 2.11 14.76
Fund with Sales Charge (%) (POP) After Shares Sold 22.76 8.21 2.48 13.37

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
Fund with Sales Charge (%) (POP) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 12/31/2019

Month EndAs of 12/31/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 27.05 35.19 35.19 36.04 19.46 349.93 979.29
Fund with Sales Charge (%) (POP) 27.05 35.19 35.19 36.04 19.46 349.93 979.29
NASDAQ Biotechnology Index (%) 21.06 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 9.07 31.49 31.49 53.17 73.86 256.66 434.87
Quarter EndAs of 12/31/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 27.05 35.19 35.19 36.04 19.46 349.93 979.29
Fund with Sales Charge (%) (POP) 27.05 35.19 35.19 36.04 19.46 349.93 979.29
NASDAQ Biotechnology Index (%) 21.06 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 9.07 31.49 31.49 53.17 73.86 256.66 434.87

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 12/31/2019 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.49 24.86 22.78
Standard Deviation (NASDAQ Biotechnology Index) 20.60 23.21 21.06
Beta 1.05 1.04 1.04
Sharpe Ratio 0.41 0.10 0.69
Information Ratio -0.02 0.01 -0.02
Tracking Error 6.08 5.78 6.01

ADDITIONAL RISK STATISTICSAs of 12/31/2019 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.01 0.95 1.04
Beta Bear 0.93 0.99 1.02
Bull Bear Capture Ratio 1.02 1.05 1.00
% of Positive Months 55.56 56.67 61.67
Gains/Losses 1.50 1.22 1.77
Maximum Drawdown
23.49 37.55 37.55

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.79%
Net Expense Ratio [further-information] 0.77%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 12/31/2019 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio 0.41
Standard Deviation 22.49

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index